Log In
BCIQ
Print this Print this
 

ALS vaccine

  Manage Alerts
Collapse Summary General Information
Company ProMIS Neurosciences Inc.
DescriptionVaccine against ALS using disease specific epitopes (DSEs) identified with its ProMIS discovery technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today